BackBristol-Myers Squibb Overview

Bristol-Myers Squibb Common Stock

Track Bristol-Myers Squibb's common stock ($290M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$292.00M

Peer trimmed avg / median

Loading

Bristol-Myers Squibb Common Stock History

Loading

Bristol-Myers Squibb vs. peers: Common Stock Comparison

Loading

Bristol-Myers Squibb Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Bristol-Myers Squibb (BMY) FAQ

As of the most recent data (June 2026), BMY shows a common stock of $290M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMY's common stock is now $290M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Bristol-Myers Squibb is outperforming or lagging.

Tracking BMY's common stock over time shows whether Bristol-Myers Squibb is scaling, shrinking, or reshaping that part of the business. The current reading is $290M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Bristol-Myers Squibb's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $290M) with ownership activity and broader fundamentals.

Bristol-Myers Squibb's common stock is $290M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.